[8-K] Iveda Solutions, Inc. Reports Material Event

Rhea-AI Filing Summary

Iveda Solutions, Inc. (IVDA) has resolved a prior Nasdaq listing deficiency. On May 27, 2025, the company was notified that it did not meet Nasdaq Capital Market standards requiring at least $2,500,000 in stockholders’ equity, or a $35 million market value of listed securities, or $500,000 of net income from continuing operations for continued listing. Based on its Form 10-Q for the quarter ended September 30, 2025, Iveda reported $3,768,242 of stockholders’ equity. Nasdaq staff advised on November 25, 2025 that the company now complies with these rules and the listing matter is closed.

Positive

• Nasdaq compliance restored: Nasdaq staff confirmed Iveda now meets the continued listing standards after reporting $3,768,242 in stockholders’ equity, closing the prior deficiency matter.

Negative

• None.

Insights

Equity & Listing Standards Analyst

Iveda cured its Nasdaq listing deficiency by reporting higher equity.

Iveda Solutions previously fell short of Nasdaq Capital Market standards that require either $2,500,000 in stockholders’ equity, a $35,000,000 market value of listed securities, or $500,000 of net income from continuing operations. Such a deficiency can ultimately threaten a company’s continued listing if not remedied.

In its Form 10-Q for the quarter ended September 30, 2025, Iveda reported stockholders’ equity of $3,768,242, above the $2,500,000 equity threshold. On November 25, 2025, Nasdaq staff determined the company once again complies with the applicable rules and closed the matter, removing this specific listing-compliance risk.

false 0001397183 0001397183 2025-11-25 2025-11-25 0001397183 IVDA:CommonStockParValue0.00001PerShareMember 2025-11-25 2025-11-25 0001397183 IVDA:CommonStockPurchaseWarrantsMember 2025-11-25 2025-11-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported) November 25, 2025

IVEDA SOLUTIONS, INC.

(Exact name of registrant as specified in its charter)

Delaware		001-41345		20-2222203
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

1744 S Val Vista, Suite 213 Mesa, Arizona		85204
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code (480) 307-8700

______________________________________________

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(g) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.00001 per share		IVDA		The Nasdaq Stock Market, LLC
Common Stock Purchase Warrants		IVDAW		The Nasdaq Stock Market, LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On May 27, 2025, Iveda Solutions, Inc. (the “Company”) received a letter from The Nasdaq Listing Qualifications Department (the “Staff”) indicating that it did not comply with Nasdaq Listing Rules 5550(b)(1), 5550(b)(2), or 5550(b)(3) (the “Rules”) which require companies listed on The Nasdaq Capital Market to maintain a minimum of $2,500,000 in stockholders’ equity, or $35 million market value of listed securities, or $500,000 of net income from continuing operations, for continued listing.

On November 25, 2025, the Company received additional correspondence from the Staff advising that, based on the Company’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025, the Company reported stockholders’ equity of $3,768,242, and, as a result, the Staff has determined that the Company complies with the Rules and that the matter is now closed.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	IVEDA SOLUTIONS, INC.
Date: November 25, 2025	/s/ David Ly
	David Ly
	Chief Executive Officer and Chairman

FAQ

What Nasdaq issue did Iveda Solutions (IVDA) disclose in this 8-K?

Iveda reported that on May 27, 2025 it received a letter from Nasdaq staff stating it did not comply with Listing Rules 5550(b)(1), 5550(b)(2), or 5550(b)(3), which require minimum levels of stockholders’ equity, market value of listed securities, or net income from continuing operations.

How did Iveda Solutions (IVDA) regain compliance with Nasdaq rules?

Based on its Quarterly Report on Form 10-Q for the period ended September 30, 2025, Iveda reported $3,768,242 in stockholders’ equity, exceeding the $2,500,000 minimum equity requirement under Nasdaq Listing Rule 5550(b)(1).

What are the specific Nasdaq Capital Market standards referenced for IVDA?

The standards referenced are Nasdaq Listing Rules 5550(b)(1), 5550(b)(2), and 5550(b)(3), which require at least $2,500,000 in stockholders’ equity, or a $35 million market value of listed securities, or $500,000 of net income from continuing operations for continued listing.

What did Nasdaq communicate to Iveda Solutions on November 25, 2025?

On November 25, 2025, Nasdaq’s Listing Qualifications Department informed Iveda that, in light of the reported $3,768,242 of stockholders’ equity, the company complies with the applicable listing rules and that the deficiency matter is now closed.

Does this 8-K indicate that Iveda Solutions remains listed on Nasdaq?

The filing states that Nasdaq staff determined Iveda complies with the continued listing rules and that the matter is closed, indicating the company has resolved the previously noted listing deficiency.

Which securities of Iveda are listed on Nasdaq according to this filing?

The filing lists Common Stock, par value $0.00001 per share (trading symbol IVDA) and Common Stock Purchase Warrants (trading symbol IVDAW) as registered on The Nasdaq Stock Market, LLC.